Safety and Tolerability of Ponesimod Compared to Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results of the Randomized, Active-Controlled, Double-Blind, Parallel-Group Phase 3 OPTIMUM Study (1770)

• DOI: 10.1212/wnl.94.15_supplement.1770
• Publication Date: 2023-12-07T05:28:50Z
• Authors: Till Sprenger; Michel Burcklen; Mark S. Freedman; Robert Fox; Eva K. Havrdová; Brian Hennessy; Reinhard Hohlfeld; Fred Lublin; Xavier Montalban; Carlo Pozzilli; Andrea Vaclavkova; Tatiana Scherz; Philippe Linscheid; Magdalena Pirozek...; Hilke Kracker; Ludwig Kappos